278 related articles for article (PubMed ID: 11661448)
1. Recombinant DNA: legal responses to a new biohazard.
Balmer TA
Environ Law; 1977; 7(2):293-313. PubMed ID: 11661448
[No Abstract] [Full Text] [Related]
2. The regulation of recombinant DNA research: the alternative of local control.
Rosenblatt DP
Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
[No Abstract] [Full Text] [Related]
3. Recombinant DNA and technology assessment.
Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
[No Abstract] [Full Text] [Related]
4. Recombinant DNA: a case study in regulation of scientific research.
Chalfant JC; Hartmann ME; Blakeboro A
Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
[No Abstract] [Full Text] [Related]
5. Reasonableness versus rationality in the construction and justification of science policy decisions: the case of the Cambridge Experimentation Review Board.
Waddell C
Sci Technol Human Values; 1989; 14(1):7-25. PubMed ID: 11650830
[No Abstract] [Full Text] [Related]
6. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
7. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
Talbot B
Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
[No Abstract] [Full Text] [Related]
8. The politics of deoxyribonucleic acid.
Budrys A
New Repub; 1977 Apr; 176(16):18-21. PubMed ID: 11662375
[No Abstract] [Full Text] [Related]
9. An unprecedented debate.
Norman C
Nature; 1977 Feb; 265(5595):575-7. PubMed ID: 11643373
[No Abstract] [Full Text] [Related]
10. Institutional biosafety committees and the inadequacies of risk regulation.
Bereano PL
Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
[No Abstract] [Full Text] [Related]
11. Recombinant DNA research: a debate on the benefits and risks.
Davis BD; Chargaff E; Krimsky S
Chem Eng News; 1977 May; 55(22):26-42. PubMed ID: 11661587
[No Abstract] [Full Text] [Related]
12. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
[No Abstract] [Full Text] [Related]
13. Recombinant DNA research: proposed revised guidelines.
U.S. National Institutes of Health
Fed Regist; 1978 Jul; 43(146):33042-178. PubMed ID: 11663829
[No Abstract] [Full Text] [Related]
14. Guidelines for research involving recombinant DNA molecules.
U.S. National Institutes of Health
Fed Regist; 1984 Nov; 49(227):46266-91. PubMed ID: 11655642
[No Abstract] [Full Text] [Related]
15. A case analysis of NEPA implementation: NIH and DNA recombinant research.
Chalker SM; Catz RS
Duke Law J; 1978 Mar; 1978(1):57-112. PubMed ID: 11661621
[No Abstract] [Full Text] [Related]
16. The Cambridge model: how public oversight of biotech is good for everyone--even business.
Lipson S
Genewatch; 2003; 16(5):7-10. PubMed ID: 15025120
[No Abstract] [Full Text] [Related]
17. Law vs. science: legal control of genetic research.
Becker F
KY Law J; 1977; 65(4):880-94. PubMed ID: 11661534
[No Abstract] [Full Text] [Related]
18. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
Karny GM
Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
[No Abstract] [Full Text] [Related]
19. The perils of knitting new life.
Lappé M
Am Biol Teach; 1977 Apr; 39(4):200-206, 210. PubMed ID: 11650656
[No Abstract] [Full Text] [Related]
20. Summary and critique of the new NIH guidelines for recombinant DNA research.
Szybalski W
Gene; 1979; 5():179-181+. PubMed ID: 11660940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
